share_log

JP Morgan Downgrades Livongo Health to Neutral, Raises Price Target to $150

Benzinga Real-time News ·  2020/10/14 05:16

JP Morgan downgrades Livongo Health (NASDAQ:LVGO) from Overweight to Neutral and raises the price target from $88 to $150.

摩根大通下调了Livongo Health(纳斯达克:LVGO)从 “增持” 至 “中性”,并将目标股价从88美元上调至150美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发